TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Cohort Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Positive Airway Pressure (PAP): Treatment of OSA with PAP

Intraoral device (IOD): Treatment of OSA with IOD

Uvuloplasty: Uvuloplasty

Conservative treatment: No active intervention

Study summary

Primary aim of the TURKAPNE (The Turkish Sleep Apnea Database) study is to generate a cross-sectional nationwide database to define clinical and polysomnographic characteristics of the sleep apnea patients in Turkey. Associations of phenotypes of sleep apnea patients with metabolic and cardiovascular diseases as well as risk for traffic accidents will be explored as secondary aims. Impact of treatment of sleep apnea on metabolic and cardiovascular complications as well as compliance with positive airway pressure treatment will be further explored longitudinally.

Eligibility

Primary outcome measure(s)

• Metabolic and cardiovascular diseases in obstructive sleep apnea phenotypes — Up to three years
  The association of sleep apnea severity indices such as Apnea-Hypopnea Index and Oxygen Desaturation Index during Rapid Eye Movement (REM) sleep and non-REM sleep with self-reported diabetes mellitus and cardiovascular diseases will be explored.

Trial sites (1)

More Koç University trials in Turkey

Other trials for the same condition